Acuren Corp. Files 8-K with Financials

Ticker: TICAW · Form: 8-K · Filed: Sep 30, 2025 · CIK: 2032966

Acuren Corp 8-K Filing Summary
FieldDetail
CompanyAcuren Corp (TICAW)
Form Type8-K
Filed DateSep 30, 2025
Risk Levellow
Pages6
Reading Time7 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

Topics: 8-K, financial-reporting, regulation-fd

TL;DR

ACRN filed an 8-K on 9/30/25, check financials.

AI Summary

Acuren Corp. filed an 8-K on September 30, 2025, reporting under Regulation FD and filing financial statements and exhibits. The filing details Acuren Corp.'s incorporation in Delaware and provides its principal executive offices in Hollywood, Florida, and Tomball, Texas.

Why It Matters

This 8-K filing provides an update on Acuren Corp.'s regulatory disclosures and financial reporting, which is important for investors to monitor the company's status.

Risk Assessment

Risk Level: low — This filing is a routine 8-K for financial statements and exhibits, not indicating any immediate material adverse events.

Key Numbers

  • 001-42524 — SEC File Number (Identifies the company's filing with the SEC.)
  • 66-1076867 — EIN (Employer Identification Number for Acuren Corp.)

Key Players & Entities

  • Acuren Corp. (company) — Registrant
  • Delaware (jurisdiction) — State of incorporation
  • Hollywood, Florida (location) — Principal executive offices
  • Tomball, Texas (location) — Principal executive offices

FAQ

What specific financial statements or exhibits are being filed with this 8-K?

The filing indicates that 'Financial Statements and Exhibits' are being filed, but the specific details of these documents are not provided in the provided text.

What is the significance of the 'Regulation FD Disclosure' item?

This indicates that the company is making disclosures in compliance with Regulation Fair Disclosure, ensuring that material information is broadly disseminated to the public.

When was Acuren Corp. incorporated?

Acuren Corp. was incorporated in Delaware, as stated in the filing.

What are the principal executive office addresses for Acuren Corp.?

The principal executive offices are located at 200 South Park Road, Suite 350, Hollywood, Florida 33021, and also at 14434 Medical Complex Drive, Suite 100, Tomball, Texas 77377.

What is the filing date of this 8-K report?

The filing date of this 8-K report is September 30, 2025.

Filing Stats: 1,759 words · 7 min read · ~6 pages · Grade level 16.8 · Accepted 2025-09-30 08:24:01

Key Financial Figures

  • $0.0001 — ch registered Common stock, par value $0.0001 per share TIC New York Stock Exchan

Filing Documents

01 Regulation FD

Item 7.01 Regulation FD . Name Change The Board of Directors of Acuren Corporation (the "Company," "we," "our," "us") approved a proposal to change our corporate name from Acuren Corporation to TIC Solutions, Inc. The name change is intended to unify our brand and corporate identity following the completion of our recent merger with NV5 Global, Inc. The name change is subject to the filing of an amendment to our Certificate of Incorporation with the Delaware Secretary of State, which we expect to occur on or about October 10, 2025. Third Quarter and Full Year 2025 Outlook We are providing the following outlook ranges for service revenue and adjusted EBITDA for the three months ending September 30, 2025, and fiscal year ending December 31, 2025: (in millions) Full Year 2025 Three Months Ending September 30, 2025 Service Revenue $ 1,530.0 to $ 1,565.0 $ 460.0 to $ 480.0 Adjusted EBITDA $ 240.0 to $ 250.0 $ 75.0 to $ 80.0 Our unaudited interim consolidated financial statements for the three- and nine-months ending September 30, 2025 are not yet available. The above outlook ranges are based on the information available to us as of the date of this Current Report on Form 8-K ("Report"). These are forward-looking statements and may differ from actual results based on, among other things, completion of our financial closing and other operational procedures, final adjustments and other developments that may arise between now and the time the financial results for the three- and nine-months ending September 30, 2025, and EBITDA and Adjusted EBITDA are non-GAAP financial measures. EBITDA is defined as earnings before interest, taxes, depreciation and amortization and Adjusted EBITDA is defined as EBITDA excluding the impact of certain non-cash and other specifically identified items. We use these non-GAAP financial measures both in explaining our results to stockholders and the investment community and

financial statements prepared in accordance with U.S. generally accepted accounting principles ("GAAP"). Accordingly,

financial statements prepared in accordance with U.S. generally accepted accounting principles ("GAAP"). Accordingly, you should not place undue reliance on these ranges. See "Cautionary Note Regarding Forward-Looking Statements" below for additional information regarding factors that could result in differences between our guidance ranges and the actual financial and other data we will report for the three- and nine-months ending September 30, 2025, and the fiscal year ending December 31, 2025. The outlook ranges were not prepared with a view toward compliance with published guidelines of the Securities and Exchange Commission or the guidelines established by the American Institute of Certified Public Accountants for preparation or presentation of prospective financial information. The ranges have been prepared by, and are the responsibility of, management. Our independent registered public accounting firm, PricewaterhouseCoopers LLP, has not audited, reviewed, examined, compiled nor applied agreed-upon procedures with respect to the outlook ranges and, accordingly, PricewaterhouseCoopers LLP does not express an opinion or any other form of assurance with respect thereto. Additionally, these non-GAAP financial measures may differ from similar measures presented by other companies. A reconciliation is not provided for the outlook ranges as we are unable to predict the amounts to be adjusted, such as the GAAP tax provision and depreciation. Accordingly, we would not be able to make a detailed reconciliation of these forward-looking financial measures available without unreasonable efforts due to our inability to predict the amount and timing of these future items. The information included in this Item 7.01 shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise Act of 1933 or

FORWARD-LOOKING STATEMENTS

FORWARD-LOOKING STATEMENTS Certain statements in this Report are "forward-looking" historical facts. The words "anticipate," "believe," "ensure," "expect," "if," "intend," "estimate," "probable," "project," "forecasts," "predict," "outlook," "aim," "will," "could," "should," "would," "potential," "may," "might," "anticipate," "likely" "plan," "positioned," "strategy," and similar expressions or other words of similar meaning, and the negatives thereof, are intended to identify forward-looking statements. Specific forward-looking statements in this Report include statements regarding the Company's expectations and beliefs regarding its outlook ranges with respect to adjusted EBITDA and service revenue. The forward-looking statements are intended to be subject to the safe harbor provided by Section 27A of the Securities Act, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements, including, among others, (i) economic conditions affecting the industries the Company serves, including the construction industry and the energy sector, as well as general economic conditions; (ii) the ability and willingness of customers to invest in infrastructure projects; (iii) a decline in demand for the Company's services or for the products and services of their customers; (iv) the fact that the Company's revenues are derived primarily from contracts with durations of less than six months and the risk that customers will not renew or enter into new contracts; (v) the Company's ability to successfully acquire other businesses, successfully integrate

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Acuren Corporation Date: September 30, 2025 By: /s/ Kristin Schultes Name: Kristin Schultes Title: Chief Financial Officer 3

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.